Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Public ClinicalTrials.gov record NCT01203631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-blind, Parallel-group, Placebo Controlled Induction Trial to Assess the Clinical Efficacy and Safety of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Europe and North America. The aim of the trial is to assess disease activity and safety in subjects with moderately to severely active Crohn's disease (CD) when treated with NNC 0142-0000-0002.
Study identification
- NCT ID
- NCT01203631
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2011 (Type not available)
- Primary completion
- May 2013 (Actual)
- Completion
- May 2013 (Actual)
- Last update posted
- Aug 1, 2016
2011 – 2013
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Clinical Trial Call Center | Anaheim | California | 92801 | — |
| Novo Nordisk Clinical Trial Call Center | Lakewood | Colorado | 80215 | — |
| Novo Nordisk Clinical Trial Call Center | Chicago | Illinois | 60637 | — |
| Novo Nordisk Clinical Trial Call Center | Louisville | Kentucky | 40202 | — |
| Novo Nordisk Clinical Trial Call Center | Annapolis | Maryland | 21401 | — |
| Novo Nordisk Clinical Trial Call Center | Chevy Chase | Maryland | 20815 | — |
| Novo Nordisk Clinical Trial Call Center | Towson | Maryland | 21204 | — |
| Novo Nordisk Clinical Trial Call Center | Chesterfield | Michigan | 48047 | — |
| Novo Nordisk Clinical Trial Call Center | Troy | Michigan | 48098 | — |
| Novo Nordisk Clinical Trial Call Center | New York | New York | 10029 | — |
| Novo Nordisk Clinical Trial Call Center | Asheville | North Carolina | 28801-4109 | — |
| Novo Nordisk Clinical Trial Call Center | Fayetteville | North Carolina | 28304 | — |
| Novo Nordisk Clinical Trial Call Center | Raleigh | North Carolina | 27612 | — |
| Novo Nordisk Clinical Trial Call Center | Germantown | Tennessee | 38138-1741 | — |
| Novo Nordisk Clinical Trial Call Center | Charlottesville | Virginia | 22911 | — |
| Novo Nordisk Clinical Trial Call Center | Milwaukee | Wisconsin | 53215-5217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01203631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2016 · Synced Sep 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01203631 live on ClinicalTrials.gov.